Seeking Alpha03/11/2026 13:59:21

BioMarin anticipates $3.8B-$3.9B 2026 revenue while flagging $70M order deferrals

BioMarin anticipates $3.8B-$3.9B 2026 revenue while flagging $70M order deferrals

1 hour ago
View Original Source
Seeking Alpha

Seeking Alpha

Seeking Alpha is the leading platform for investors to research and discuss US-traded stocks and ETFs. Our platform helps investors to find successful investing ideas and to successfully manage their portfolios. It provides investment ideas, analysis, news, ratings, investing tools and community discussion.

More from Seeking Alpha

Regeneron Pharmaceuticals, Inc. 2026 Q3 - Results - Earnings Call Presentation

5 min ago

Exelon Corporation 2026 Q3 - Results - Earnings Call Presentation

7 min ago

Autoliv expands commercial vehicle business with MCF Safety Belts buy

8 min ago

Palantir Q3: This Small Sell-Off Isn't Enough (Rating Downgrade)

8 min ago